Search research articles
Contact Us
Filters
Showing results (1-10 of 167) with videos related to
Page
of 17
Sort By:
Journal of Interventional Cardiology
|
October 6, 2006
Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough
James E Tcheng
Journal of Interventional Cardiology
|
March 25, 2005
Hospital percutaneous coronary intervention volume and outcome: does it matter?
James E Tcheng, Steve Kindsvater
JACC. Cardiovascular Interventions
|
February 5, 2010
Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion
James E Tcheng, David A Zidar
American Heart Journal
|
January 7, 2003
Double negatives
David E Kandzari, James E Tcheng
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 10, 2012
Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients
James E Tcheng, Steven M Mackay
JACC. Cardiovascular Interventions
|
July 1, 2019
Artificial Intelligence and Machine Learning in Cardiology
R Jeffrey Westcott, James E Tcheng
Advances in Therapy
|
December 19, 2009
Prasugrel: Clinical development and therapeutic application
Daniel R Guerra, James E Tcheng
Journal of the American College of Cardiology
|
October 3, 2006
After fibrinolysis: is cardiac catheterization the answer?
James E Tcheng, Kurt G Kinney
Current Interventional Cardiology Reports
|
February 15, 2001
Eptifibatide in Percutaneous Coronary Intervention: The ESPRIT Trial Results
J. Conor O'Shea, James E. Tcheng
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Quantitative and qualitative comparison of text-based and graphical user interfaces for Computerized Provider Order Entry
R Clayton Musser, James E Tcheng
Page
of 17
Search research articles
Search
Showing results (1-10 of 167) with videos related to
Sort By:
Page
of 17
Journal of Interventional Cardiology
|
October 6, 2006
Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough
James E Tcheng
Journal of Interventional Cardiology
|
March 25, 2005
Hospital percutaneous coronary intervention volume and outcome: does it matter?
James E Tcheng, Steve Kindsvater
JACC. Cardiovascular Interventions
|
February 5, 2010
Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion
James E Tcheng, David A Zidar
American Heart Journal
|
January 7, 2003
Double negatives
David E Kandzari, James E Tcheng
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 10, 2012
Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients
James E Tcheng, Steven M Mackay
JACC. Cardiovascular Interventions
|
July 1, 2019
Artificial Intelligence and Machine Learning in Cardiology
R Jeffrey Westcott, James E Tcheng
Advances in Therapy
|
December 19, 2009
Prasugrel: Clinical development and therapeutic application
Daniel R Guerra, James E Tcheng
Journal of the American College of Cardiology
|
October 3, 2006
After fibrinolysis: is cardiac catheterization the answer?
James E Tcheng, Kurt G Kinney
Current Interventional Cardiology Reports
|
February 15, 2001
Eptifibatide in Percutaneous Coronary Intervention: The ESPRIT Trial Results
J. Conor O'Shea, James E. Tcheng
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Quantitative and qualitative comparison of text-based and graphical user interfaces for Computerized Provider Order Entry
R Clayton Musser, James E Tcheng
Page
of 17